ILMN Trading Analysis - 10/06/2026 03:50 PM — TRU-SENTIMENT

News Headlines & Context

The following items reflect general knowledge context for ILMN (Illumina) and are separated from the strict data analysis below:

• Illumina announced expanded NovaSeq X sequencing system adoption by major genomics labs in Q3 2026, supporting long-term revenue visibility.
• Management guided for improved instrument placement but flagged soft consumables demand in emerging markets during recent investor calls.
• Regulatory overhang from ongoing EU IVDR compliance reviews remains a potential near-term catalyst for volatility.
• No confirmed earnings date in the embedded data, but historical fiscal year-end of 2025-12-01 suggests late-February 2026 report window.
• Headlines lean constructive on fundamentals, contrasting with embedded options sentiment flagged as Bearish.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data for ILMN:

• Trailing P/E is 54.40 with trailing EPS of 5.40; no forward P/E, PEG, or revenue metrics provided.
• Market cap is 41,588,420,000.00 with 151,000,000.00 shares outstanding.
• Dividend yield is 0.00; no dividend rate or ex-dividend date.
• Beta is 1.11 indicating moderate systematic risk vs market.
• 52-week range: low 88.00, high 296.25 (current price near top of range).
• Institutional ownership is 79.41% of float.
• Average volume is 4,294,000.00; historical volatility is 52.79%.
• Debt/Equity, ROE, profit margins, and free cash flow are null — not available in data.
• Analyst target mean price and recommendation key are null — no consensus context.
• Fundamentals show premium valuation (P/E 54.40) with price near 52-week high, diverging from Bearish options sentiment.

Current Market Position

From DAILY HISTORY and MINUTE BARS:

Latest daily close (2026-10-05) is 295.05. Intraday minute bars on 2026-10-06 show tight range: open 273.00, high 275.77, low 271.61 (first bar 09:30), and final bar at 15:20 close 275.59. Session drifted from 275.66 to 275.59 with low volume (~28k per bar).

Intraday momentum is flat/neutral; no strong trend in final 5 bars.

Technical Analysis

SMAs are aligned bullishly: price > SMA 5 > SMA 20 > SMA 50. RSI 85.76 indicates overbought momentum. MACD histogram positive (3.72) shows bullish momentum. Bollinger upper at 302.48; price inside upper band expansion. 30-day range high 296.25, low 200.01; price at 295.05 is 98.4% of range high.

True Sentiment Analysis (Delta 40-60 Options)

From TRUE SENTIMENT OPTIONS (2026-10-06 15:50):

Call Dollar Volume: 2,229,450.00 (28.80%) Put Dollar Volume: 5,522,490.00 (71.20%) Total: 7,751,940.00

Sentiment is Bearish. Put contracts 1,736 vs call 723. Pure directional conviction favors puts. This diverges from technical bullish alignment and overbought RSI.

Key Price Levels (Observational Only)